Aisling Capital Management LP Biomea Fusion, Inc. Transaction History
Aisling Capital Management LP
- $243 Million
- Q3 2024
A detailed history of Aisling Capital Management LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 798,757 shares of BMEA stock, worth $3.22 Million. This represents 3.32% of its overall portfolio holdings.
Number of Shares
798,757
Previous 798,757
-0.0%
Holding current value
$3.22 Million
Previous $3.59 Million
124.46%
% of portfolio
3.32%
Previous 1.57%
Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
104Shares Held
17.8MCall Options Held
1.68MPut Options Held
410K-
Cormorant Asset Management, LP Boston, MA3.57MShares$14.4 Million2.53% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$9.45 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$8.5 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$5.63 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.38MShares$5.55 Million0.01% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $118M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...